Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan UBC Medical Indonesia Tbk. dan Brigit Biofarmaka Teknologi Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp174 (kapitalisasi pasar 691,25 M, volume 24 jam 635,5 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 4,2× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (635,5 rb vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 691,25 M | 166,01 M |
Volume | 635,5 rb | 324 rb |
Lot | 6,36 rb | 3,24 rb |
Perputaran | 110,15 jt | 77,68 jt |
Harga Rata-rata | 173,33 | 239,75 |
Nilai Transaksi | 110,15 jt | 77,68 jt |
Harga Ekuilibrium Indikatif | 174 | 240 |
Volume Ekuilibrium Indikatif | 50 | 1 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
